|
|
Article: DOR BioPharma Reports Fourth Quarter and Year End Financial Results and Accomplishments for 2003.
- Article from:
- Business Wire
- Article date:
- March 31, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
MIAMI--(BUSINESS WIRE)--March 31, 2004
DOR BioPharma, Inc., (AMEX:DOR), a biopharmaceutical company focused on biodefense vaccines and therapeutics for unmet medical needs, today announced financial results for the fourth quarter and year ended December 31, 2003.
Net loss for fourth quarter 2003 was approximately $1.4 million, or $0.05 per share, compared to $1.1 million, or $0.05 per share, for fourth quarter 2002. The Company's net loss for the year 2003 was approximately $6.2 million, or $0.21 per share, compared to $6.4 million, or $0.29 per share, for the year 2002. The increased net loss for the ...